紛美包裝(00468.HK)預計中期純利約1.56億元
格隆匯6月25日丨紛美包裝(00468.HK)公吿,根據集團於2021年1月1日至2021年6月24日(包括首尾兩日)期間 最近期業績的初步評估及現時可得資料,預計集團於期間所錄得的綜合純利將介乎約人民幣1.37億元至人民幣1.47億元。公司截至2020年6月30日止6個月期間的綜合純利約為人民幣1.56億元。
集團於期間的綜合純利預計減少主要歸因於原料成及銷售開支較去年同期大幅增加。有關增加主要受全球短缺及商品價格增加導致原料價格上升;以及國際運費成增加所帶動。倘上述情況持續且並無任何重大改善,則預期集團截至2021年12月31日止年度的綜合純利將較截至2020年12月31日止年度有進一步百分比減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.